Thymosin immunotherapy in patients with small cell carcinoma of the lung: correlation of in vitro studies with clinical course.
D002272:Carcinoembryonic Antigen / Q000032:analysis; D002283:Carcinoma, Bronchogenic / Q000097:blood / Q000401:mortality / Q000628:therapy*; D018288:Carcinoma, Small Cell / Q000097:blood / Q000401:mortality / Q000628:therapy*; D006023:Glycoproteins / Q000097:blood; D006801:Humans; D007111:Immunity, Cellular; D007958:Leukocyte Count; D008175:Lung Neoplasms / Q000097:blood / Q000401:mortality / Q000628:therapy*; D013601:T-Lymphocytes; D013947:Thymosin / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*
D002272:Carcinoembryonic Antigen; D006023:Glycoproteins; D013951:Thymus Hormones; D013947:Thymosin